News - GlaxoSmithKline


Current filters:


Popular Filters

176 to 200 of 445 results

Investigation on-going as claims GSK staff may have broken Chinese law


Sales staff at UK pharma major GlaxoSmithKline (LSE: GSK) in China may have broken Chinese law, the company…


China says GSK probe part of business climate clean-up


China's probe into UK pharma major GlaxoSmithKline (LSE: GSK) was part of the country's efforts to improve…

Asia-PacificGlaxoSmithKlineLegalMarkets & MarketingPharmaceutical

US Court denies re-hearing of Arzerra patent case


Danish drugmaker Genmab (OMX: GEN) says that the US Court of Appeals for the Federal Circuit has declined…

ArzerraBiogen IdecBiotechnologyGenentechGenmabGlaxoSmithKlineLegalNorth AmericaOncologyPatentsPharmaceutical

China probe into GlaxoSmithKline bribery allegations escalates


Investigations in China relating to alleged bribery and tax-related crimes by UK pharma giant GlaxoSmithKline…

Asia-PacificGlaxoSmithKlineLegalMarkets & MarketingPharmaceutical

GlaxoSmithKline and Theravance withdraw Japan NDA for Relvar Ellipta in COPD


UK pharma giant GlaxoSmithKline (LSE: GSK) and US partner Theravance (Nasdaq: THRX) revealed on Friday…

Asia-PacificBiotechnologyGlaxoSmithKlinePharmaceuticalRegulationRelvar ElliptaRespiratory and PulmonaryTheravance

GSK executives investigated in China over bribery and tax-related crimes


Executives at UK pharma giant GlaxoSmithKline (LSE: GSK) in China are being investigated on suspicion…


GlaxoSmithKline files sNDAs for combination melanoma drugs


UK pharma giant GlaxoSmithKline (LSE: GSK) said today (July 9) that it has submitted supplemental New…

BiotechnologyGlaxoSmithKlineMekinistNorth AmericaOncologyPharmaceuticalRegulationTafinlar

Immunocore in multi-million deal with GlaxoSmithKline on ImmTACs


Oxford, UK-based biotech firm Immunocore, focused on developing novel biological drugs called ImmTACs…


FDA backs Baxter's Rixubis for hemophilia B; Breakthrough status for GSK's drisapersen


The US Food and Drug Administration yesterday (June 27) approved Baxter International's (NYSE: BAX) Rixubis…

Baxter InternationaldrisapersenGlaxoSmithKlineNorth AmericaPharmaceuticalRare diseasesRegulationRixubis

More ADA highlights, from Eli Lilly on dulaglutide, J&J on Invokana and GSK on albiglutide


Continued news from the 73rd Scientific Sessions of the American Diabetes Association being held in Chicago,…

albiglutideDiabetesdulaglutideEli LillyGlaxoSmithKlineInvokanaJohnson & JohnsonLY605541PharmaceuticalResearch

Japan vaccines briefs: Gardasil and Cervarix; Daiichi Sankyo files NDA


The Japanese Ministry of Health, Labor and Welfare has decided to withdraw its recommendation for a vaccination…

Asia-PacificCervarixDaiichi SankyoGardasilGlaxoSmithKlineMerck & CoPharmaceuticalRegulationVaccinesWomen's Health

Pfizer, GSK and Siemens join R&D consortium with A*STAR' on pharma production


US and UK pharma giants Pfizer (NYSE: PFE) and GlaxoSmithKline's (LSE: GSK) units Pfizer Asia Pacific…


Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site


UK pharma giant GlaxoSmithKline (LSE: GSK) said yesterday (June 18) that it has received an offer for…

ArixtraAspen PharmacareCardio-vascularFraxiparineGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalProduction

Global asthma market to reach 159 million lifetime cases by 2022


Over 300 million people suffer from asthma, which translates to a drug market worth over $15 billion.…

GlaxoSmithKlineGlobalMarkets & MarketingMerck & CoPharmaceuticalRespiratory and PulmonarySeretideSingulair

Majority vote from FDA advisory panel to ease restrictions on GSK's Avandia


A joint advisory committee to the US Food and Drug Administration (FDA) voted to continue to make UK…

AvandiaDiabetesGlaxoSmithKlineNorth AmericaPharmaceuticalRegulation

Aqua Pharma acquires Verdeso Foam from GSK


West Chester-based, USA, Aqua Pharmaceuticals says it has acquired the US rights to, and re-launch of,…

Aqua PharmaceuticalsDermatologicalsGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalVerdeso

GlaxoSmithKline's Tykerb/Tyverb and chemotherapy combo fails in gastric cancer


UK pharma giant GlaxoSmithKline (LSE: GSK) says that its study of Tykerb/Tyverb (lapatinib) in combination…


176 to 200 of 445 results

Back to top